Rajavithi Hospital Hospital
Recent work: Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Hydroxychloroquine for Treatment of COVID-19 : A Randomized Control Trial (THDMS-COVID-19)
Technology:
COVID Labs/Universities
Industry:
COVID R&D
Headquarters:
Thailand
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership